CPHI’s Annual Report predicts huge impact of AI on drug development and manufacturing.
Ahead of CPHI Barcelona, which will occur October 24–26, 2023, the CPHI Annual Report explores future trends, challenges, and opportunities (1). Featuring a panel of more than 12 industry analysts and insights from 400 pharmaceutical executives, the report provides a window into both near-term and medium-term opportunities in the pharma sector. In this article, the author delves into the implications of artificial intelligence (AI) on drug development and pharmaceutical manufacturing.
Bikash Chatterjee is president and chief science officer at Pharmatech Associates–a USP Company.
Read this article in the Trends in Formulation 2023 eBook.
Pharmaceutical Technology
Trends in Formulation eBook
October 2023
Pages: 34–44
When referring to this article, please cite it as Chatterjee, B. The Impact of AI on Pharma. Pharmaceutical Technology Trends in Formulation 2023 eBook. October 2023.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.